# Melatonin for Prevention of Post- Operative Delirium Pilot Study Protocol

> **NCT02903901** · PHASE4 · WITHDRAWN · sponsor: **Loyola University**

## Conditions studied

- Delirium

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02903901
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-06
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator found that a new study drug that is FDA approved would be superior to melatonin
- **Last updated:** 2016-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02903901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02903901, "Melatonin for Prevention of Post- Operative Delirium Pilot Study Protocol". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02903901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
